Factors associated with chronic abdominal pain in patients with inflammatory bowel disease in remission: A pilot cross‐sectional study
Neurogastroenterology & Motility · 2024
DOI: 10.1111/nmo.14881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, 2024. Verfasst von Maike Engelmann-Kewitz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuroscience, Surgery and Trauma, Wingate Institute of Neurogastroenterology, Barts and The London School of Medicine and Dentistry, Unive…. Hauptthemen laut MEDLINE: Abdominal Pain, Inflammatory Bowel Diseases, Chronic Pain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients (20%–50%) with inflammatory bowel disease (IBD) experience chronic abdominal pain during remission. The clinical features of IBD patients with abdominal pain during remission remain poorly characterized. This cross‐sectional pilot study aimed to assess patient recruitment, adherence, and feedback to optimize questionnaires for future use and to determine the clinical features that distinguish IBD patients in remission with and without abdominal pain.
Methods
Online validated questionnaires about disease activity, symptoms, and psychological factors were sent to participants of the UK National Institute for Health and Care Research (NIHR) IBD BioResource, which is a national research platform consisting of re‐callable IBD patients designed to expedite research into Crohn's and colitis. Inclusion/exclusion criteria of the IBD BioResource main cohort were applied. Descriptive and inferential statistics were applied to participants in remission. p ‐values ≤0.01 were considered significant. Key results A total of 2050 patients were approached; 291 (14.2%) of these agreed to participate. In 35 patients, technical problems, length, and poor understanding of the relevance of some questionnaires affected completion as confirmed by feedback. In total, 244 patients were full responders with 122 (50%) in remission; 33 (27%) of these had chronic abdominal pain. Comparison of those with versus without ( n = 89) chronic abdominal pain yielded higher scores in patients with pain for the following: somatization ( p < 0.001); gastrointestinal symptoms rating scale score ( p =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Neuroscience, Surgery and Trauma, Wingate Institute of Neurogastroenterology, Barts and The London School of Medicine and Dentistry, University of London, London, UK.
- Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
- Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
- Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
- Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, St Marks Hospital, London, UK.
- Department of Pharmacology, University of Cambridge, Cambridge, UK.
Zitieren
APA
Engelmann-Kewitz, M., Khwaja, I., Takahashi, K., Parkes, M., Norton, C., Hart, A., Bulmer, D., & Aziz, Q. (2024). Factors associated with chronic abdominal pain in patients with inflammatory bowel disease in remission: A pilot cross‐sectional study. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14881
Vancouver
Engelmann-Kewitz M, Khwaja I, Takahashi K, Parkes M, Norton C, Hart A, et al. Factors associated with chronic abdominal pain in patients with inflammatory bowel disease in remission: A pilot cross‐sectional study. Neurogastroenterology & Motility. 2024. doi:10.1111/nmo.14881
BibTeX
@article{EngelmannKewitz2024,
author = {Engelmann-Kewitz, Maike and Khwaja, Iman and Takahashi, Kazuya and Parkes, Miles and Norton, Christine and Hart, Ailsa and Bulmer, David and Aziz, Qasim},
title = {Factors associated with chronic abdominal pain in patients with inflammatory bowel disease in remission: A pilot cross‐sectional study},
journal = {Neurogastroenterology & Motility},
year = {2024},
doi = {10.1111/nmo.14881}
}
EUVIMED